Dendritic cell-targeting chemokines inhibit colorectal cancer progression
Aim: Recent progress in cancer immunotherapy has shown its promise and prompted researchers to develop novel therapeutic strategies. Dendritic cells (DCs) are professional antigen-presenting cells crucial for initiating adaptive anti-tumor immunity, therefore a promising target for cancer treatment....
Spremljeno u:
Glavni autori: | Pengkun Yuan (Autor), Yunyi Zhou (Autor), Zhixue Wang (Autor), Liming Gui (Autor), Bin Ma (Autor) |
---|---|
Format: | Knjiga |
Izdano: |
Open Exploration Publishing Inc.,
2022-12-01T00:00:00Z.
|
Teme: | |
Online pristup: | Connect to this object online. |
Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
Slični predmeti
-
Chemokines in Cancer Development and Progression and Their Potential as Targeting Molecules for Cancer Treatment
od: Naofumi Mukaida, i dr.
Izdano: (2014) -
Allogenic mouse cell vaccine inhibits lung cancer progression by inhibiting angiogenesis
od: Jun Zhao, i dr.
Izdano: (2021) -
VHH antibody targeting the chemokine receptor CX3CR1 inhibits progression of atherosclerosis
od: Sarah Low, i dr.
Izdano: (2020) -
Targeting Mcl-1 Degradation by Bergenin Inhibits Tumorigenesis of Colorectal Cancer Cells
od: Yu Gan, i dr.
Izdano: (2023) -
The Inflammatory Chemokine CCL5 and Cancer Progression
od: Donatella Aldinucci, i dr.
Izdano: (2014)